Bann Khraisat

Bann Khraisat

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2021 in International Journal of Psychiatry in Clinical Practice
Verified
Journal Article
Closed access
BKBann Khraisat
Bann Khraisat
ATAhmad Amjed Toubasi
Ahmad Amjed Toubasi
LALujain AlZoubi
Lujain AlZoubi
TAThuraya Al-Sayegh
Thuraya Al-Sayegh
AMAhmad Mansour
Ahmad Mansour
This meta-analysis aims to estimate the pooled prevalence of mental disorders among COVID-19 survivors.The databases Pubmed, Google Scholar, ScienceDirect, and medRxiv have been searched up to 1 Au...

3 February 2022 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
BKBann Khraisat
Bann Khraisat
AAAhmad Mufeed Al-Jeady
Ahmad Mufeed Al-Jeady
DADana Ayman Alqatawneh
Dana Ayman Alqatawneh
ATAhmad Amjed Toubasi
Ahmad Amjed Toubasi
Saif Aldeen AlryalatSaif Aldeen Alryalat
Saif Aldeen Alryalat

8 July 2024 in Journal of Pediatric Health Care
Verified
Journal Article
Closed access
MHManar M. Hasuneh
Manar M. Hasuneh
ATAhmad A. Toubasi
Ahmad A. Toubasi
BKBann Khraisat
Bann Khraisat
HAHamdi Aldabbas
Hamdi Aldabbas
MAMontaha Al-Iede
Montaha Al-Iede

1 August 2021 in Archives of Medical Research
Verified
Journal Article
Closed access
ATAhmad Amjed Toubasi
Ahmad Amjed Toubasi
RARand Bilal AbuAnzeh
Rand Bilal AbuAnzeh
BKBann Khraisat
Bann Khraisat
TAThuraya Nael Al-Sayegh
Thuraya Nael Al-Sayegh
Saif Aldeen AlryalatSaif Aldeen Alryalat
Saif Aldeen Alryalat

9 January 2024 in International Journal of Neuroscience
Verified
Journal Article
Closed access
MEMaha Elbeltagy
Maha Elbeltagy
BKBann Khraisat
Bann Khraisat
LALujain AlZoubi
Lujain AlZoubi
LHLeen Hmoud
Leen Hmoud
AAAhmad AlJeady
Ahmad AlJeady
ASAhmed Salman
Ahmed Salman
AimThis work explores the effect of Cisplatin-a chemotherapeutic agent known to cause deterioration in cognitive function in cancer patients, and spatial memory in mice. It also investigates the potential neuroprotective effects of Piracetam, which is a nootropic drug recognized for improving cognitive ability.Materials and methodsThe study incorporates four groups of mice receiving varied medication regimens, with memory tested using the Novel Location Recognition (NLR) method.ResultsThe findings from our study revealed that memory decline and a suppression of cellular proliferation were observed in adult male mice subjected to Cisplatin treatment; furthermore, a decline in antioxidant efficacy within the hippocampal dentate gyrus was evident. Moreover, analysis of treatment effects on the animals' weight revealed that the Cisplatin and Piracetam group exhibited the most significant weight loss during drug administration. Despite the significant weight loss, the simultaneous use of Cisplatin and Piracetam demonstrated a notable improvement in memory and an augmentation of hippocampal proliferation and antioxidant effect.LimitationsIt is important to note that our study was hampered by budget limits, a lack of additional animals, and mice's low tolerance for protracted treatment.ConclusionsShould the outcomes of Piracetam observed in this investigation be applicable to patients, it might offer a relatively straightforward approach to mitigate the cognitive impacts endured by cancer survivors following exposure to chemotherapy. Future research will be needed to study Piracetam's effect on mice with brain cancer after Cisplatin treatment in order to extrapolate the results onto cancer patients.

26 September 2024 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
FAFatima Alnaimat
Fatima Alnaimat
SASalameh Al-Halaseh
Salameh Al-Halaseh
LALujain AlZoubi
Lujain AlZoubi
BKBann Khraisat
Bann Khraisat
ONOsama Mohammad Hussein Abu Nassar
Osama Mohammad Hussein Abu Nassar